• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Johnson & Johnson (NY:JNJ)

    230.00 UNCHANGED
    Streaming Delayed Price Updated: 7:00 PM EDT, May 19, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 8,536
    Open 230.00
    Bid (Size) 230.00 (200)
    Ask (Size) 230.60 (100)
    Prev. Close 230.00
    Today's Range 230.00 - 230.00
    52wk Range 149.04 - 251.71
    Shares Outstanding 2,628,679,824
    Dividend Yield 2.26%
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    These 3 Dividend Stocks Are as Close to a Sure Thing as Investing Gets ↗
    ExxonMobil, Johnson & Johnson, and Coca-Cola are safe stocks to buy and forget. 
    Via The Motley Fool
    Topics ETFs Energy
    News headline image
    3 Dividend Kings to Buy and Hold for 20 Years ↗
    When it comes to reliable dividend payouts, these three companies keep rewarding their long-term shareholders. 
    Via The Motley Fool
    Topics Retirement

    Performance

    YTD
    +10.9%
    +10.9%
    1 Month
    -0.3%
    -0.3%
    3 Month
    -5.5%
    -5.5%
    6 Month
    +15.0%
    +15.0%
    1 Year
    +50.8%
    +50.8%

    More News

    Read More
    News headline image
    Meet the Dividend King With a Higher Credit Rating Than the U.S. Government ↗
    Via The Motley Fool
    Topics Economy
    Johnson & Johnson (NYSE:JNJ) Screens Well as a Dependable Dividend Aristocrat ↗
    Via Chartmill
    News headline image
    3 Dividend Stocks Warren Buffett Would Buy in a Market Crash ↗
    Via The Motley Fool
    CNS Drug Delivery Technologies Are Reshaping Alzheimer’s and Biodefense Research
    Via Investor Brand Network
    InvestorNewsBreaks – Oncotelic Therapeutics, Inc. (OTCQB: OTLC) Featured in BioMedWire Editorial on Next-Generation CNS Drug Delivery
    Via Investor Brand Network
    Topics Intellectual Property
    News headline image
    CNS Drug Delivery Technologies Are Reshaping Alzheimer’s and Biodefense Research
    From BioMedWire
    Via GlobeNewswire
    News headline image
    Johnson & Johnson Advances the Standard of Calcium Modification with Global Launch of Shockwave™ C2 Aero Coronary IVL Catheter
    From Johnson & Johnson
    Via Business Wire
    News headline image
    Is Bristol Myers Squibb Stock Overvalued at Nearly $60? A Reality Check for Value Investors. ↗
    Via The Motley Fool
    Topics Intellectual Property
    News headline image
    Johnson & Johnson to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference
    From Johnson & Johnson
    Via Business Wire
    News headline image
    Income or Growth: Which Healthcare Stock Fits Your Portfolio Right Now? ↗
    Via The Motley Fool
    Topics Economy Retirement Stocks
    News headline image
    2 Dividend Stocks That Are No-Brainer Buys in May ↗
    Via The Motley Fool
    Topics Economy
    News headline image
    These Market Signals Alarm Me, but I Still See Profit Potential in These 3 Consumer Stocks ↗
    Via The Motley Fool
    News headline image
    3 Unstoppable Dividend King Stocks to Buy Right Now for Less Than $550 ↗
    Via The Motley Fool
    News headline image
    Safer Dividend King to Buy Now: AbbVie or Johnson & Johnson? ↗
    Via The Motley Fool
    Topics Intellectual Property
    News headline image
    Is Johnson & Johnson Still the Ultimate Safe Dividend Stock to Buy? ↗
    Via The Motley Fool
    News headline image
    Johnson & Johnson Announces Pivotal Clinical Study Results for a New Soft-Tissue Surgical Robotic System
    From Johnson & Johnson
    Via Business Wire
    News headline image
    Are Wall Street Analysts Bullish on Johnson & Johnson Stock?
    Via Barchart.com
    Topics ETFs
    News headline image
    The Best Dividend Stocks to Buy and Hold Forever ↗
    Via The Motley Fool
    News headline image
    Got $1,000? Which of These Beaten-Down Healthcare Stocks Is Worth Buying? ↗
    Via The Motley Fool
    Topics World Trade
    News headline image
    Johnson & Johnson Appoints Ryan Koors as Vice President, Investor Relations
    From Johnson & Johnson
    Via Business Wire
    News headline image
    Want to Build Real Wealth in Healthcare? These Stocks Are Worth Considering ↗
    Via The Motley Fool
    News headline image
    Johnson & Johnson to Participate in the Bernstein’s 42nd Annual Strategic Decisions Conference
    From Johnson & Johnson
    Via Business Wire
    News headline image
    Is Bristol Myers Squibb the Best Bargain in Big Pharma? ↗
    Via The Motley Fool
    Topics Intellectual Property

    Frequently Asked Questions

    Is Johnson & Johnson publicly traded?
    Yes, Johnson & Johnson is publicly traded.
    What exchange does Johnson & Johnson trade on?
    Johnson & Johnson trades on the New York Stock Exchange
    What is the ticker symbol for Johnson & Johnson?
    The ticker symbol for Johnson & Johnson is JNJ on the New York Stock Exchange
    What is the current price of Johnson & Johnson?
    The current price of Johnson & Johnson is 230.00
    When was Johnson & Johnson last traded?
    The last trade of Johnson & Johnson was at 05/19/26 07:00 PM ET
    What is the market capitalization of Johnson & Johnson?
    The market capitalization of Johnson & Johnson is 604.60B
    How many shares of Johnson & Johnson are outstanding?
    Johnson & Johnson has 605B shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.